Integrum implements new compensation package for its CEO

28.03.25 09:07 Uhr

MÖLNDAL, Sweden  , March 28, 2025 /PRNewswire/ -- Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has implemented a new compensation package for its Board Director and Acting CEO Scott Flora.

"Integrum is currently undergoing a major strategic shift. As part of this work, the board has renegotiated Acting CEO Scott Flora's compensation package to increase focus on performance-based compensation. The recruitment of a permanent CEO is ongoing, and the new agreement with Scott Flora provides continued stability and growth focus in the executive management team during this transition phase," comments Kristofer Westergren, Board Director of Integrum and coordinator of the business assessment and strategic shift. 

The new incentive program is based on Stock Appreciation Rights ("SARs") for the Board Member and Acting CEO Scott Flora. Within the framework of the program, Scott Flora has been granted 200,000 SARs, where each vested SAR entitles to a compensation based on Integrum's share price, but not exceeding SEK 60, on the day of exercise of the vested SARs, less an exercise price (so-called Base Price) amounting to SEK 29.30 per SAR. The granted SARs will vest at a rate of 20 percent every three months starting from June 1, 2025. Unvested SARs will lapse and will not entitle the holder to any payment. A vested SAR shall be exercisable during 1 September 2026 to 31 October 2026. The SAR payment may be paid in stock or in cash, at the Integrums election.

In connection with the new incentive program taking effect, the fixed compensation to Scott Flora will be reduced. The incentive program falls within the framework of the guidelines for compensation to senior executives adopted at Integrum's most recent shareholders' meeting.

For more information, please contact:
Jörgen Svanström, CFO
Phone: + 46 (0) 70 734 96 60
E-mail: Jorgen.svanstrom@integrum.se

Certified Adviser
Carnegie Investment Bank AB (publ) is the company's Certified Adviser.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/integrum-ab/r/integrum-implements-new-compensation-package-for-its-ceo,c4127020

The following files are available for download:

https://mb.cision.com/Public/17531/4127020/a7e38c1ac82b8947.pdf

Integrum implements new incentive program for CEO

 

 

 

Cision View original content:https://www.prnewswire.com/news-releases/integrum-implements-new-compensation-package-for-its-ceo-302414123.html

SOURCE Integrum AB

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Nachrichten zu Barnes Group Inc.

Wer­bung

Analysen zu Barnes Group Inc.

DatumRatingAnalyst
18.05.2018Barnes Group NeutralD.A. Davidson & Co.
19.01.2017Barnes Group HoldSunTrust
07.04.2016Barnes Group NeutralAlembic Global Advisors
07.04.2016Barnes Group BuyDeutsche Bank AG
26.10.2015Barnes Group OutperformOppenheimer & Co. Inc.
DatumRatingAnalyst
07.04.2016Barnes Group BuyDeutsche Bank AG
26.10.2015Barnes Group OutperformOppenheimer & Co. Inc.
22.04.2005Update Barnes Group Inc.: BuyJefferies & Co
DatumRatingAnalyst
18.05.2018Barnes Group NeutralD.A. Davidson & Co.
19.01.2017Barnes Group HoldSunTrust
07.04.2016Barnes Group NeutralAlembic Global Advisors
20.10.2006Update Barnes Group Inc.: NeutralRobert W. Baird
16.10.2006Update Barnes Group Inc.: HoldBB&T Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Barnes Group Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen